BioPharma Credit PLC (LON:BPCR)

London flag London · Delayed Price · Currency is GBP · Price in USD
0.9420
+0.0120 (1.29%)
Mar 25, 2026, 4:35 PM GMT
Market Cap784.21M -2.2%
Revenue (ttm)117.21M +5.1%
Net Income96.51M +6.3%
EPS0.08 +14.0%
Shares Out1.13B
PE Ratio8.16
Forward PEn/a
Dividend0.07 (10.70%)
Ex-Dividend DateFeb 19, 2026
Volume1,103,198
Average Volume1,095,718
Open0.9380
Previous Close0.9300
Day's Range0.9200 - 0.9500
52-Week Range0.8000 - 0.9798
Beta0.18
RSI53.52
Earnings DateMar 24, 2026

About BioPharma Credit

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. The company debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in Leeds, the United Kingdom. [Read more]

Sector Financials
Founded 2016
Country United Kingdom
Stock Exchange London Stock Exchange
Ticker Symbol BPCR
Full Company Profile

Financial Performance

In 2025, BioPharma Credit's revenue was $157.75 million, an increase of 5.14% compared to the previous year's $150.03 million. Earnings were $129.89 million, an increase of 6.31%.

Financial numbers in USD Financial Statements